MissionIR Articles
Original content written and distributed as part of our ongoing relationships.
-
MissionIRNewsBreaks – Correlate Energy Corp. (CIPI) Addressing ‘Significant Problem’ with Resilient Energy Solutions
Correlate (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, is driving scalability in the microgrid energy distribution market. This follows a new partnership between its subsidiary Distributed…
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting Oral GLP-1 Alternatives for Diabetes and Obesity Treatment
Data from the United States shows that 54% of adults and 66% of children consume more added sugars than recommended (https://ibn.fm/W2oXd). On average, it has been noted that adults, young adults, and children in the…
-
D-Wave Quantum Inc. (NYSE: QBTS) Expands Product Roadmap to Bring Power of Quantum to Artificial Intelligence & Machine Learning
D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, has announced a significant expansion of its Leap quantum cloud service, targeting advancements in…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Publishes Q2 2024 Results
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today released its financial results for the second quarter…
-
MissionIRNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports Q2 2024 Financial Results, Shares Business Update
Scinai Immunotherapeutics (NASDAQ: SCNI) is a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices business unit. The company today published its financial results for…
-
MissionIRNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) CEO Showcases Strategic Approach to Industry
McEwen Mining (NYSE: MUX) (TSX: MUX) is an asset-rich diversified gold and silver producer in the Americas. McEwen CEO Rob McEwen recently spoke at the NYC SME’s 9th Annual Current Trends in Mining Finance Conference,…
-
Annovis Bio Inc. (NYSE: ANVS) Lead Compound Shows Synergistic Cognitive Enhancement
Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company, announced new preclinical data demonstrating lead compound buntanetap’s potential to synergistically enhance cognition when used in combination with the glucagon-like peptide 1 (GLP-1) agonist dulaglutide…
-
McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Releases Q2, H1 Financial Results, Key Update on Argentinian Mining Project
McEwen Mining (NYSE: MUX) (TSX: MUX), an asset rich diversified gold and silver producer in the Americas with a large exposure to copper through its subsidiary McEwen Copper, released its second-quarter and half-year 2024 financial…
-
MissionIRNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Signs Definitive Loan Restructuring Agreement with EIB Converting Debt into Equity
Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices business unit, today announced the signing of a definitive Loan Restructuring…
-
MissionIRNewsBreaks – SOBR Safe Inc. (NASDAQ: SOBR) Releases Q2 2024 Quarterly Update
SOBRsafe (NASDAQ: SOBR), a provider of next-generation, transdermal alcohol-detection solutions, is reporting on its NASDAQ listing, financial positioning and sales progress, noting that the NASDAQ Hearings Panel granted the company an exception period continuing the…
-
D-Wave Quantum Inc. (NYSE: QBTS) Sees Double Digit Growth in 1H 2024 Training Enrollments with Workforce Development Initiative
D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, and the first commercial provider of quantum computers, recently announced a significant increase in enrollment for its quantum training courses. In the…
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Q3 2024 Financial Results; Offers a Roadmap for its Key GLP-1 Study Program
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just released its fiscal report for the third quarter of the 2024 financial year (“Q3, 2024”). Of note was growth in cash and marketable…
-
Clene Inc.’s (NASDAQ: CLNN) Makes Significant Strides in Developing its Lead Agent, CNM-Au8(R), to Address Neurodegenerative Conditions
Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc. is a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple…
-
Rising Domestic Violence Incidents Represents Expanding Opportunity for EM Tech Innovator SuperCom Ltd. (NASDAQ: SPCB)
The severe consequences of domestic violence incidents are driving the monitoring of offenders’ whereabouts via electronic GPS-enabled technologies. Tennessee enacted a law last month described as the first in the nation to codify measures statewide…
-
Annovis Bio Inc. (NYSE: ANVS) Secures U.S. Patent Covering Methods For Treating TBI and Preventing Nerve Cell Death With Buntanetap
Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company, announced the issuance of a U.S. patent for treating traumatic brain injury (“TBI”) with its lead drug candidate, buntanetap. Initially filed in 2016, the patent…
-
D-Wave Quantum Inc. (NYSE: QBTS) Expands Commercial Partnership with Zapata Computing Holdings Inc. (NASDAQ: ZPTA), Hosts B.C. Dignitaries at Quantum Engineering Center of Excellence
D-Wave Quantum (NYSE: QBTS), a pioneer in quantum computing systems, software, and services, and Zapata Computing Holdings (NASDAQ: ZPTA), known for its expertise in industrial generative AI software solutions, have announced a notable expansion of their…
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Exploring Alternative Diabetes and Obesity Treatments
According to the International Diabetes Federation Diabetes Atlas of 2021, 10.5% of adults aged between 20 and 79 globally have diabetes. In addition, almost half of them are unaware that they are living with the…
-
InMed Pharmaceuticals Inc. (NASDAQ: INM) Subsidiary BayMedica Releases Market Report for 2023 on “Minor Cannabinoids”
With the increasing acceptance of cannabis use in society, the popularity of edibles—products containing cannabinoids that can be consumed as food or drink—has surged. While many consumers are familiar with edibles containing THC (tetrahydrocannabinol), known…
-
MissionIRNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Reports on Clinical Data Showing Lead Compound Combined with GLP-1 Agonist Enhances Cognition
Annovis Bio (NYSE: ANVS), a late-stage, clinical-drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), is reporting preclinical data regarding its lead compound, buntanetap. According to the…
-
Clene Inc. (NASDAQ: CLNN) Advances Neurodegenerative Disease Treatment with Innovative Nanotherapeutics
Clene (NASDAQ: CLNN), a pioneering biopharmaceutical company, is making significant strides in the treatment of neurodegenerative diseases through its novel nanotherapeutic platform. With a mission to improve underlying mitochondrial health and protect neuronal function, Clene…
-
Correlate Energy Corp. (CIPI) Makes Energy Transition an Attainable Option for Climate-conscious Customers
Companies worldwide are working to build environmental, social and governance (“ESG”) initiatives, while meeting the expectations of investors. A recent Deloitte survey indicates that a majority of US companies report progress on sustainability (https://ibn.fm/ZDILd). At…
-
MissionIRNewsBreaks – SenesTech Inc. (NASDAQ: SNES) Schedules Call, Webcast to Report Q2 2024 Financial Results
SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal-pest populations, has announced plans for a conference call and webcast to be held on Aug. 8, 2024, at 5 p.m. ET. According to the…
-
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Announces Conference Call, Webcast to Discuss Q2 Results
HeartBeam(NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has scheduled a conference call and webcast to discuss its second-quarter 2024 results. According to the announcement, the…
-
SuperCom Ltd. (NASDAQ: SPCB) Technology Delivers Needed Solution to World’s Growing Domestic Violence Prevention Concerns
Electronic monitoring (“EM”) technology is finding a place as a significant and accessible solution for preventing domestic violence. A recent fact sheet from StalkingAwareness.org (https://ibn.fm/yN3B0) shows a particular need for enforcing protective orders worldwide to prevent stalking…
-
SenesTech Inc. (NASDAQ: SNES) Providing Non-Lethal Rodent Pest Management Solutions Amid Growing Conversation About Unintended Bird Deaths
Back in 2020, a study published by Tufts Wildlife Clinic and Cummings School of Veterinary Medicine showed that 100% of the Red-tailed Hawks admitted into their clinic tested positive for rodenticides. Earlier this year, Flaco,…
-
Correlate Energy Corp. (CIPI) Making Solar Energy Affordable and Accessible by Making the Process Easy and Seamless
According to Solar Power Europe, it is projected that in 2024, global solar capacity will reach 2.2 TW, up from 1.6 TW in 2023. It is further projected that in 2028, this number will hit…
-
MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Announces Date for Release of Q2 2024 Financial Results
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, will release its financial results for the second quarter of 2024 on Aug. 8, 2024, before the market opens. The…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) to Participate as an Anchor Organization at the 2024 Southeastern United States – Canadian Provinces Business Forum
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is participating as an Anchor Organization and panelist at the 2024 Southeastern United States – Canadian Provinces (“SEUS-CP”) Business Forum. The 2024 SEUS-CP is set…
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Produces Notable Findings in Latest Weight Loss Study
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery enhancement, just released interim results from its WEIGHT-A24-1 animal study. The study evaluated the company’s patented DehydraTECH technology and its potential to address diabetes and…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Long-Term Study Results Confirm Positive Results of Developing Treatment for AD
InMed Pharmaceuticals (NASDAQ: INM), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, is reporting on positive results from a long-term study of…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Inks Exclusive License in ‘Transformational’ Step to Treating GBM
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has entered into an exclusive license agreement with Cortice…
-
Correlate Energy Corp. (CIPI) Building Toward NYSE Uplist as it Meets Opportunities of Decentralized Energy Trend
A combination of unprecedented levels of government incentives and growing private sector investment funding are pushing a noteworthy shift in energy trends as decentralized electrical energy generation gains an increasing following, according to an MSE…
-
Annovis Bio Inc. (NYSE: ANVS) Announces FDA Approval to Transition to New Form of Buntanetap for Future Clinical Trials
Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders like Alzheimer’s and Parkinson’s, just announced that the U.S. Food and Drug Administration (“FDA”) has given approval for Annovis…
-
SuperCom Ltd. (NASDAQ: SPCB) EM Technology Highly Competitive in Expanding Field of Court-administered Offender Monitoring
The use of electronic monitoring (“EM”) to track the whereabouts of domestic violence or other offenders has risen steadily over the last 40-plus years since the state of Florida’s Department of Corrections became the first…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Receives Order for Mullen Campus EVs from Leading Transportation and Logistics Company
Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, has received an order for four Mullen Campus electric vehicles from DB Schenker, one of the world’s leading transportation and logistics companies. According to the announcement,…
-
Clene Inc. (NASDAQ: CLNN) Discusses Important Developments of CNM-Au8(R) and Its Novel Technology During Xtalks Podcast
Xtalks Life Science Podcast recently featured Karen S. Ho, PhD, Vice President of Translational Medicine for Clene (NASDAQ: CLNN), a late-stage biopharmaceutical company focused on protecting mitochondrial health and neuronal function to treat neurodegenerative diseases. In…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Receives PO from European Distributor for 29 Mullen GOs
Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, has received an order for 29 Mullen GOS from one of its newest European distribution partners. The order for the GOs, which are Mullen’s commercial micro-urban-delivery…
-
MissionIRNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Receives US Patent for Methods of Treating Acute Traumatic Brain Injury with Its Lead Drug Candidate
Annovis Bio (NYSE: ANVS), a late-stage, drug-platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s (“AD”) and Parkinson’s disease (“PD”), today announced the receipt of U.S. Patent No. 12,042,482. The patent covers methods of…
-
InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-089, a Promising Treatment for Age-Related Macular Degeneration
Age-related macular degeneration (“AMD”) is a prevalent eye condition that primarily affects older adults, leading to vision loss in the central part of the retina, known as the macula. This disease significantly impacts the quality…
Search Articles
Latest Articles
- MissionIRNewsBreaks – FAVO Capital (OTC: FAVO) President Shaun Quin Joins Forbes Business Council
- MissionIRNewsBreaks – Solowin Holdings (NASDAQ: SWIN) Signs MOU With CITIC to Develop Digital Infrastructure in Saudi Arabia
- MissionIRNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Is Pushing the Boundaries of Performance in Growing Market
- Nutriband Inc. (NASDAQ: NTRB): When Regulatory Momentum Meets Leadership Continuity
- MissionIRNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Highlighted in Italian Press for Juve Stabia Player Development, Market Value Surge